Abivax Société Anonyme
(NASDAQ) ABVX
Abivax Société Anonyme Financials at a Glance
Market Cap
$9.71B
Revenue (TTM)
$10.79M
Net Income (TTM)
$458.26M
EPS (TTM)
$-5.41
P/E Ratio
-22.65
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$122.77
Volume
28,024
Open
$121.69
Price
$122.77
Volume
28,024
Open
$121.69
Previous Close
$122.77
Daily Range
$119.53 - $122.99
52-Week Range
$5.59 - $148.83
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$122.77
Volume
28,024
Open
$121.69
Previous Close
$122.77
Daily Range
$119.53 - $122.99
52-Week Range
$5.59 - $148.83
ABVX News
ABVX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Abivax Société Anonyme
Industry
Biotechnology
Sector
Health CareEmployees
69
CEO
Marc M. P. de Garidel, EMBA
Website
www.abivax.comHeadquarters
Paris, 75008, FR
ABVX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-48%
Return on Assets
-58%
Earnings Yield
-4.42%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$9.71B
Shares Outstanding
79.29M
Volume
28.02K
Short Interest
0.00%
Avg. Volume
953.29K
Financials (TTM)
Gross Profit
$1.03M
Operating Income
$240.73M
EBITDA
$239.70M
Operating Cash Flow
$155.69M
Capital Expenditure
$136.40K
Free Cash Flow
$155.83M
Cash & ST Invst.
$530.16M
Total Debt
$32.08M
Abivax Société Anonyme Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.02M
-186.7%
Gross Profit
$3.05M
-231.0%
Gross Margin
0.00%
N/A
Market Cap
$9.71B
N/A
Market Cap/Employee
$140.74M
N/A
Employees
69
N/A
Net Income
$222.05M
-131.8%
EBITDA
$146.11M
-58.7%
Quarterly Fundamentals
Net Cash
$498.08M
+145.4%
Accounts Receivable
$10.49M
-45.1%
Inventory
$0.00
N/A
Long Term Debt
$30.78M
+14.9%
Short Term Debt
$1.30M
-95.8%
Return on Assets
-57.52%
N/A
Return on Invested Capital
-48.08%
N/A
Free Cash Flow
$23.32M
+67.3%
Operating Cash Flow
$23.23M
+67.4%